News stories about Advanced Accelerator Application (NASDAQ:AAAP) have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Advanced Accelerator Application earned a coverage optimism score of 0.24 on Accern’s scale. Accern also gave media stories about the company an impact score of 45.9026636242167 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Shares of AAAP opened at $81.63 on Friday. The stock has a market capitalization of $3,589.76, a PE ratio of -240.09 and a beta of 0.69. Advanced Accelerator Application has a 52-week low of $35.11 and a 52-week high of $82.74.
A number of equities analysts have commented on AAAP shares. BidaskClub downgraded shares of Advanced Accelerator Application from a “hold” rating to a “sell” rating in a research report on Thursday, January 11th. ValuEngine upgraded shares of Advanced Accelerator Application from a “sell” rating to a “hold” rating in a research report on Friday, February 2nd. Finally, Zacks Investment Research downgraded shares of Advanced Accelerator Application from a “hold” rating to a “sell” rating in a research report on Tuesday, January 30th. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $69.80.
Advanced Accelerator Application Company Profile
Advanced Accelerator Applications SA is a radiopharmaceutical company. The Company develops, produces and commercializes molecular nuclear medicine (MNM), diagnostic and therapeutic products. MNM uses trace amounts of radioactive compounds to create functional images of organs and lesions and to treat diseases, such as cancer.
Receive News & Ratings for Advanced Accelerator Application Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Accelerator Application and related companies with MarketBeat.com's FREE daily email newsletter.